Loading publications…
The last 5 uploaded publications
Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma
Shatha AbuHammad, Carleen Cullinane, Claire Martin, Zoe Bacolas, Teresa Ward, Huiqin Chen, Alison Slater, Kerry Ardley, Laura Kirby, Keefe T. Chan, Natalie Brajanovski, Lorey Smith, Aparna D. Rao, Emily J. Lelliott, Margarete Kleinschmidt, Ismael A. Vergara, Anthony T. Papenfuss, Peter K. H. Lau, Prerana Ghosh, Sue Haupt, Ygal Haupt, Elaine Sanij, Gretchen Poortinga, Richard B. Pearson, Hendrik Falk, David J. Curtis, Paul A. Stupple, Mark Devlin, Ian P. Street, Michael A. Davies, Grant A. McArthur, Karen E. Sheppard (2019). Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma. , 116(36), DOI: https://doi.org/10.1073/pnas.1901323116.
Article62 days agoPalbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance
Claire Martin, Carleen Cullinane, Laura Kirby, Shatha AbuHammad, Emily J. Lelliott, Kelly Waldeck, Richard J. Young, Natalie Brajanovski, Donald P. Cameron, Rachael Walker, Elaine Sanij, Gretchen Poortinga, Ross D. Hannan, Richard B. Pearson, Rodney J. Hicks, Grant A. McArthur, Karen E. Sheppard (2017). Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance. , 142(10), DOI: https://doi.org/10.1002/ijc.31220.
Article62 days ago